Meeting
2019 ASCO Annual Meeting
Association of PIK3CA mutations (mut) with immune engagement and clinical benefit from immunotherapy in microsatellite stable (MSS) colorectal cancer (CRC) patients (pts).
Authors
Maliha Nusrat
Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX
Maliha Nusrat , Jason Roszik , Riham Katkhuda , David Menter , Kanwal Pratap Singh Raghav , Van K. Morris II, Padmanee Sharma , James Patrick Allison , Jorge M. Blando , Dipen M. Maru , Gregory Lizee , Filip Janku , Michael J. Overman , Scott Kopetz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 37, 2019 (suppl; abstr 3604)
DOI
10.1200/JCO.2019.37.15_suppl.3604
Abstract #
3604
Poster Bd #
96
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Molecular comparison of primary colorectal cancer (pCRC) with peritoneal metastases (PM).
First Author: Matthew K Stein
Poster
2024 ASCO Genitourinary Cancers Symposium
Comprehensive analysis of targetable alterations in urachal cancer by NGS.
First Author: David Joseph Benjamin
First Author: Sandra Algaze
Poster
2020 ASCO Virtual Scientific Program
The landscape of MAP3K1/MAP2K4 alterations in gastrointestinal (GI) malignancies.
First Author: Matthew K Stein